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Mynstbenia ~avis is an organ-specific autoimmune were deteeted in 2 1% of patieocs with OMG but in no disorder ienerally tbougbt to be calUed by an anti patient with GMG. Antibodies re-cogniring puri.fted body-mediated attack against tbe skeletal muscle Qico succinate dehydrogenase (67 kOal were found in 42% tin.ic acetylcboline (Acb) receptor (AchR) at tbe neuro o(patients with OMG, in 100% (5 o(5 ) o fparients with muscular junction. ExtraocuJar muscle weakness aud GMG, and in 48% ofa..lJ patients with myasthenia gravis double vision are pre8ent in about OOC< of patients with n ot associated with Graves' hyperthYroidism.. There myasthenia gravis and are the predominant com was D O close c orrela t ion between any e~e muscle-reac plaints in about 20% of patients. when the condition is tive antibo dy and 8.ntibodie9 agaio.st tbe AchR in ei cal led ocular myasthe nia gravis (OMG). While serum ther group or myasthenic patients. The findiogs sup antibodie9 agai.n8t the AchR are detected in mO!it pa port the notion that immunoreactivity ago.iost skeletal tients with generaJiozed myasthenia gravis (GMG), they .Q\usele proteins other than the AcbR may playa role are not round in about one-third of patients with the in tbe development of the mWlc:le wt'akness in AchR oeular variety. and epidemiolotjfical. clinical, and sere· antibody-negative patienls witb O;\IG and G~IG. al log;caJ studies: s uggest that OMG and GMG are two tbough it is u.oJikely that any oftbe antibodies demon separate diseases. Both fo rms efmyasthenia gravis are strated in this study are directly i.mpUc att'd. Similarly, sometimes associated with tbyroid autoimmunity or while the demonstration of antibodit's reacrive with thyroid-associated ophthalmopathy (TAO). We have eye muscle antigen.9 associated with TA.O in patient9 therefore tested tbe sera of patient.<; with GMG and with OMG raise" the possibility that tbt' link between OMG by Western blotting for antibodies agawt por· the oculax lesions of myasthenia p-a..-is and Graves' cine eye m uscle membrane proteins in general. a.cd by disease may be autoimmu.o..ity Gga.i.ru:t a common anti· e.n.zyme-liuked immunOliorbent assays (ELISA) lipe "en(s), it is more like ly that both disorders are medi· cifically fOJ: reaction with two skeletal muscle antia-eus ated by cytotoxic T cells recogn.izi.n.g anotber cell mem wbich are prominent marker antigens for TAO, brane untiien, s u c h as tbe novel th)'T'Oid and eye mU9 namely. the calcium-binding protein calsequestrin cle shared protein G2s, and that iCnun antibodies and !..be so-called "64·kDe. protein frequently found antibodies were those target ing e y e muscle membrane proteins of 15. 67 . and 110 kDa. Anti · Mya.sthenia gravis is a n orgsn ' ;peciric aUh'Lmm u ne disorde r ge ne ra lly th ought t o be ca u3e'd b~' Rn :1n1ibody med ia ted a tta ck agai nst t he skel e! al muscle nicot inic acetylcholine (Ach ) receptor (AchR · at the nl'U fo mUSC U- That serum antibodies agai nst the AchR are detected in 90% ofpat.ients with GMG but in only 65% with the oc ular variety (10, 11) suggests that othe r antibodies may playa role in the development of eye muscle weak ness in OMG. Myasthenia gravis is li nked with autoimmune thy roid disease in that approximately 5% of the patients also have Graves' hyperthyroidism or H ashimoto's thy roiditis (12, 13). Thyroid-associated ophthalmopathy (TAO) 1S an au toimmune disorder of the extraocular (eye) muscle and orbital connective ti ssue closely asso clated with Graves' hyperthyroidism (reviewed in 14) . OMG and TAO share some clinical features and may occur in the same patient. rn a recent study, Manno et al. ( l S) s howed tha t when myasthenia gravis was associated w"ith thyroid autoimmunity, i.t tended to have a milder clinic al expression with preferential ocu lar involvement and lower frequencies of thymic dis ease and AchR antibodies. This association was partic u la rly strong in patients with ophthalmopa thy a nd thy roid autoimmunity (15) . We ha\-e thus studied patients with GMG aod OMG for serum autoantibodies reactive with eye muscle antigens, including two recently iden tified as being associated with TAO, namely, the Fp s ubunit of mitochondrial s uccinate dehydrogenase (the "64 kDa protein") (16) and calsequestrin , a 63 -kD a cal cium-bin ding protein localized in the sarcoplasmic re ticulum of the skeletal muscle fiber ( 17). We demon strated antibodies agains t one or more eye muscle pro teins of M, IS-110 kDa in 100« of patients \vith OMG and 88% of patients with GMG. and against succin ate dehydrogen ase Fp in 42% of patients with OM G and 100% with GMG.
CUNICAL SUBJECTS .~""lJ METHODS

Clinical Su.bjects
The studies concerned patient s with the foll owing:
(Il Generalized m_vasthcl1io grOl.:IS (GMGJ. Five males and two fema les. of whom twO had associ a ted Crave s' h yperLhyro idism. were :;:rudied. The diagnosis was made from the typi ca l hls!Ol"Y and cl inical exami nation, including oph thalmologic assessment, and can· firmed by t he tensilon test. Only one patient had detect· able seru m antibodies against the AchR.
(ii) Ocular myasthenia gravis (OMG). Sixteen m ales a nd 17 fema les, of whom 7 had ass ociated Graves' hyperth)'"Toidism and 1 had Hashimoto's thy roiditis, we re a lso studied . The diagnosis was made from the typicaJ history and clinical ex:aminalion, in cluding ophth almologic assessment and confirmed by the tensilon test. Eighteen of the patients had detect able serum antibodies against the AchR Patients with ophtha lmopathy and myasthenia were excluded from t h e study.
(iiij No rmal subjects. Tweoty-one mal es and 33 fe males, aged-m atched with myasthenic patients, with no personal or family history of myasthenia gravis, thy roid disease, op h tha lmopa th..~, or other autoimmune disease, were r ecruited from ancillary hospital and lab oratory s taff.
The study was IRE approved and informed written consent was obtained from aU patients and normal sub jects stud ied .
SDS -PAGE and Western Blornng
Antibodies reactive with porcine eye muscle mem brane proteins and purified beef b eart succinate dehy drogenase Fp subunit were dececced following standard Laemmli SDS-PAGE (18) using an 8.5% separating gel and a 4% stacking gel in a minigel apparatus, as reported previously (19, 20 ' . Primary antibodies were patie nts' sera dilu ted 110 and a rabbit anti·flavoprotein subunit antiserum diluted L:2000. and secondary anti body was an alkaline phosphatase-conjugated anti-hu man IgG (y chain specific, antisennn diluted 112000, for patients' sera, or anti-rabbit rgG (whole molecule) antiserum diluted mooo, for the anti-Fp antiserum.
Tests were read by two obseT\ers and results were ex pressed as band density. A band density of + or greater was taken as a positive test.
Isolation of Purified Beef Heart .Huscle Succinate Dehydrogenase
Succinate dehydrogenase conraini ng the Fp and I p (iron -su lfur protein) subunits was solubili zed by per chlorate treatment (2 1) of suc("inate:coenzyme Q modo reducta se (complex H of the respiratory chain), which had been isolated from beef he>an mitochondria by the method ofBagin sky and Hal eR 22 J The enzyme prepa ratlon was >90Ck pure ba:;:ed on gel analysis and con tent of cova le ntl y bound fta,; n adenine din ucleotide. Pure enzym e was excised from S DS-polyacry lamide gel s according to th e meth od of :' I lerii e( 0/. (23 ) and used D.S a ntigen in We5tt'rn blotting a nd EUSA.
Isolation. of Purified Porcine Eye Muscle Calsequestnn
Pig eye mu scl e was homoge nized in a prechilled ble nder and cent rifuged at 13,OOOg for 30 min . Ammo nium s ulfate was added to the supernatant to a final concentration of 92% and the pH was adj usted to 4.7 -with phosphoric acid . The precipitate from this step was collected by centrifugation at 13 ,OOOg fo r 30 min, dissolved in Tri s-phosphate buffer, and dialyzed again st the sa me buffe r. The sample was then applied to a DEAE-SephaceJ CO IUTTUl and preequilibrated with buffer A (0.1 M potassium phosphate, pH 7.1, 1 mM EGTA, 50 mM NaCD. Buffer B CO.1 M potassium phos phate , pH 7. 1, 1 roM EGTA, '700 mM NaCI) was then applied and 3-m l fracti ons were collected, moni toring absorbance at 280 nM. Two-hundred-microliter ali quots were taken from every third fraction and sub jected to Western blot analysis to check reactivity with an anti-calseQ,uestrin monoclonal antibody in order to identify those tubes containing calsequestrin. Purified calsequestrin was used as antigen in EUSA
Enzyme Lmked Immunosorbent Assay
The method has been described }n pre ..;ous publica tions from this labor atory (24 , 25) . The oprimal antigen concentration was found to be 1 .ug'ml for both calsequestrin a nd succinate dehydrogeoase and the op timal serum dilution was 1125. The setood antibody "is an alkaline phosphatase-labeled goat anti-human IgG (U1500 dilution). Results are expressed as optical den s"ity (0 0) at 410 nm and positi ve reactivi ty against test antigen is taken as mean + 2 SD for DOrmal subjects tested concurrently.
S tatistica l Analysts
Differences in mean (= SE) values between pa tient groups and normals in EUSA was assessed statisti cally using the Student t test. Differences in preva lences of serum autoantibodies reactive with eye mus cle membrane antigens in imruunoblottiog, and with Fp and calsequestrin in ELISA, be tween patient and control groups, were assessed using X 2 tests.
RESULTS
We tested sera from 7 patients with GMG, 33 pa tients with OMG, and 54 normal subjects, as contr ols, for a ntibodies against porcine eye muscle membra ne antigens utilizing 80S -PAGE and West ern blotting , and agai nst succinate dehydrogenase fp and caJse questri n in ELISA. Patients with OM G Wf're furt her classified as a nti-AchR a ntibody positi ,·e ' 18 pa tients: grou p n or a nti-AchR o.ntibody negatiye ' 15 pa tie nts; grou p 10. Seven patien ts with OMG had as."ocia ted Graves' hyperthyroid ism but no ophthalmopathy. Pa ti ents with GM G. of whom only one Wa3 anti-AchR a nhbody pos itive and two had assoo J U'd Graves' hy_ pe rthyroidism , were studied as a si.r.gle group (7 pa tients; group III ). The resu lts are su.-nman zed in Fig.  1 a nd Table 1 . One or more serum an tibodi es against porcine eye muscle membrane proteins of M , illa were detected in 100% of palient.3 with G.\1G and in 88% with OMG (Table 1 ). Next, w~ tested for serum anti bodies against purified Fp and calsequestrin in ELISAs. Anti-Fp a ntibody levels "in the ::hree groups of patients and the normals are depicteC in Fig. 1 We studied patients with GMG anaO~IG for serum au toantibodies reactive with porcine .:-:;~ muscle mem bra ne antigens, "including two antige:l." closely associ, ated with TAO, na mely, the succinau d~h ydroge o ase Fp subunit, which is incorrectly referred to 111 the liter ature as the 64-kDa protein, a nd ca ls.:-:f.UeHnn . a 63 kDa calcium-binding proteio. To sumoanze the main results, antibodies reactive with na t:\"" ca. : .~eques trin were detected in 21% of patients Ili t:-_O:'>IG bur in nO patient with GMG, whil e a ntibodie::: toimmuni!y and O\'ert ophthalmopathy were excluded though antibodies reactive with the A.ch R play an im from t.he s lUdy . 1I .ieems highly likely that the antlbod portant role (1,. While myasthenia gravil> is us ually a ies were associ'lled with myastherua r ather than TAO. generalized fue::\se, the skeletal mu"de autoimmun e:
The pathogenesis of myas thenia gravis is unclear a1-reaction and resulting weakness and f.atiga bili t.y m ay (19, 20, 27. 281 and p!'"€ 'dicrors of its development in patients with th:\Toid auroimmuruty, especially Graves' hyperthyroidism (29.30·. The 64-kDa protein has reo cently been partially sequenced and identified as the Fp suburut of mitochonc..";al succinate dehydrogenase (16). The recalculated Jf, of the 64-kDa protein is 67 kDa. In a recent study. antibodies against purified sue· cinate dehydrogenase \\'ere detected in 67% of patients with active TAO, in 30r;. vrith stable TAO and in 30% of patients with Gra,"e~' hyperthyroidism without oph thalmopathy, but in only i"k of age-and sex.matched nonnal subjects, by immunoblotting ( 16). Another pro tein associated with TAO is calsequestrin, a 63-kDa calcium-binding protein which is localized in the sarco plasmic reticulum of the muscle fiber (17). Calseques· trin is known to share an epiwpe ".tith heat shock pro· tein 60 (3U. A..ntibodie::: against calsequestrin were found in 401k ofpatieD!': \'Oth active TAO, but in only 4% of those with stable, ""burnt out," eye disease, and in 5% of nonnal subj~, by immunoblotting (G unji et al., submitted ). In conciu..o:ion, while antibodies agai nst eye muscle antigens associated with TAO are found in the majori ty or patieot.; with myasthe nia gravis, it is like ly that the musel.:; damage of myasthenia is medi . aled by CDS-(cytOtoxic! T lymphocytes targeti ng an ' other , cell membrane, antigen, s uch as the recently doned thyroid a nd eye muscle shared protein G2s (32), and that the a ntibodies measured in this study are Sl:COlld;lr.\ n;>.Ilk!!r" of immUlIc-Ol.. diatcd , ' \1: ll1 u~dt damage in both di~o rd(' rs .
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